Griscelli syndrome type 2

Griscelli syndrome type 2 (GS2) is an autosomal recessive hereditary disorder that combines partial hypopigmentation with severe immunodeficiency. It is caused by biallelic variants in the RAB27A gene, which alter the vesicular trafficking necessary for pigment distribution and for immune cells to eliminate infected or activated cells.

The RAB27A gene encodes the Rab27a protein, a small GTPase involved in the transport, docking, and secretion of intracellular vesicles. This protein participates in specialized processes of different cell types, particularly in melanocytes and cytotoxic immune cells. In melanocytes, Rab27a facilitates the transport of melanosomes to the cell periphery so that pigment can be correctly transferred to the skin and hair. When Rab27a does not function properly, melanosomes aggregate abnormally, leading to characteristic hypopigmentation with silvery or light gray hair. In cytotoxic T lymphocytes and natural killer cells, Rab27a allows the release of cytotoxic granules. Its deficiency reduces the ability to destroy infected cells and favors episodes of excessive immune activation, known as hemophagocytic lymphohistiocytosis (HLH). Inheritance is autosomal recessive, and the disease is ultrarare, although clusters have been described in populations with higher consanguinity or founder effects, such as families from the Maghreb, Middle East, or Turkey.

Symptoms

The onset of SG2 usually occurs in childhood. The most characteristic signs are partial hypopigmentation, with silvery or grayish hair, light skin, and irregular pigment clumps in the hair shaft, along with a marked predisposition to develop HLH/LHH. This hyperinflammatory phase can occur with persistent fever, hepatosplenomegaly, cytopenias, liver dysfunction, and neurological symptoms such as irritability, seizures, or deterioration of the general state. Without treatment, HLH/LHH can be life-threatening.

Disease management

Management requires early diagnosis and urgent control of HLH/LHH episodes through immunosuppression, chemotherapy, and supportive treatment. Hematopoietic stem cell transplantation (HSCT) is the only treatment with curative potential for the immunological defect and is recommended before irreversible neurological damage occurs. Partial albinism is managed with photoprotection, dermatological and ophthalmological follow-up, and family genetic counseling.

Genes analyzed

RAB27A U
U Ultra Whole Genome Sequencing 30x

Bibliography

What do your genes say about you? Start your journey today.

Get a special 5% discount on your first kit.

Haven't you taken our DNA test yet?

Get your genetic test and discover what your DNA says about you.

pack
Starter DNA test
The best option to get started

Ancestry service, Traits and Wellness

Buy
pack
DNA test Advanced DNA test
Know your DNA in depth

Health, Ancestry service, Traits and Wellness

Buy
pack
Genetic analysisUltra
Whole Genome Sequencing 30x

Health, Ancestrality, Traits and Wellness

includes three months of tellmeGen+

Buy

Important information and limitations

Europe
Austria
Belgium
Czech Republic
Denmark
Finland
Germany
Hungary
Ireland
Italy
Netherlands
Norway
Poland
Portugal
Romania
Spain
Sweden
Switzerland
United Kingdom
Asia
Kazakhstan
Saudi Arabia
UAE
America
Brazil
Canada
Chile
Colombia
Mexico
Panama
Peru
United States
Oceania
Australia
The Best Prices of the Year! Only until November 27 Use our coupon BLACK15
Buy